Depression and Anxiety Trial, Recruiting NCT06162624 Sponsor: University of Wisconsin, Madison Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06162624
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People with a reading level of 6th grade or higher, as measured by a specific reading test called the Wide Range Achievement Test
  • People who are experiencing moderate or severe levels of anxiety and/or depression, as measured by two standard questionnaires (the Beck Depression Inventory-II and Beck Anxiety Inventory)
  • People who are not currently engaging in self-harm and do not have active thoughts of suicide
  • People who are not scheduled to be transferred or released within the next three months
  • People who are willing and able to take part, including having permission and access to basic study materials such as paper and a pen or pencil

Who may not be able to join:

  • People who are unable to give informed consent to participate in the study
  • People who are currently engaging in self-harm or who have active thoughts of suicide
  • People who are scheduled to be transferred or released within the next three months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Koenigs, PhD, University of Wisconsin, Madison

Phone: 920-602-5612

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 December 2024
Est. completion
30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Eligible participants; Participants who choose to participate; Percentage of participants that complete all 8 weeks; Qualitative Summary of Reasons for Attrition; Number of Participants referred for Follow up care; Participant Satisfaction; Change in Mental Health: Flexibility; Change in Mental Health: Automatic Thoughts; Change in BAI Score; Change BDI-II Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov